Zero-Day Exploit Response Guide for Dialysis EHR Vendors

How should dialysis EHR vendors assess a suspected zero-day exploit?

Treat credible evidence of an unknown or unpatched vulnerability being exploited as an active security incident, even before you can confirm the attacker’s access or the full impact. Separate what is known, suspected, and not yet determined; do not equate a vulnerability report with proof that every customer environment was compromised.

Start a coordinated response involving security, engineering, product, support, legal, privacy, and customer-facing teams. Identify the affected product components, versions, configurations, hosting models, interfaces, and dependencies. Determine whether the vulnerable code is present and reachable in each deployment, and whether indicators suggest attempted or successful exploitation.

Assess both confidentiality and operational impact. Look for unauthorized access to electronic protected health information (ePHI), unexpected changes to clinical records, service disruption, and access to connected systems. Establish a timeline using available EHR audit logs, authentication records, application events, and infrastructure telemetry. Record uncertainties and update findings as evidence develops.

If your organization is a HIPAA business associate, follow your business associate agreement (BAA) and applicable incident procedures. HHS explains that business associates must respond to and document security incidents, and that BAAs must provide for reporting security incidents to the covered entity. Coordinate promptly with affected dialysis providers so they can assess clinical and privacy impacts. HHS guidance on business associate security-incident reporting

Use a documented response process that moves through detection and analysis, containment, recovery, and lessons learned. NIST SP 800-61 Rev. 3 provides current incident-response recommendations for organizations.

How can vendors contain the incident while maintaining dialysis care?

Contain the exploit path as narrowly as practical, while coordinating with each customer’s clinical and IT leaders. Before disabling a feature, interface, service, or connection, assess whether it supports treatment workflows, patient records, scheduling, medication documentation, or other critical operations. The clinical organization should determine whether and how to use its downtime procedures.

Where feasible, isolate affected hosts, services, accounts, or network paths rather than taking an entire EHR environment offline. Apply network segmentation controls to limit lateral movement between affected systems and clinical networks. Restrict unnecessary remote access and administrative privileges, block known malicious traffic, and disable a vulnerable function only when its clinical consequences are understood and an alternative workflow is ready.

Maintain clinical system availability through customer-approved contingency planning procedures. These may include a tested downtime workflow, an approved read-only mode, or secure manual documentation, followed by reconciliation when systems are restored. Define who can authorize a switch to downtime operations, how staff will access essential information, and how records will be protected and entered into the EHR afterward. HHS describes contingency planning as including backup, recovery, and procedures for continuing critical business processes in emergency mode. HHS summary of the HIPAA Security Rule

Do not assume that isolating a system by disconnecting it is risk-free: actions can affect evidence or trigger other system behavior. Capture necessary volatile information when safe and practicable, then use a response plan that balances containment, evidence preservation, and patient-care continuity. Keep customers informed about what has been isolated, what remains available, known limitations, and the next decision point.

What logs and artifacts should teams preserve?

Preserve evidence early, before routine troubleshooting, cleanup, or patching changes the affected systems. Prioritize relevant EHR audit logs that record access and changes to clinical records, along with authentication events, application and database logs, API activity, remote-access records, endpoint alerts, and network, DNS, firewall, and cloud audit data. Capture configuration files, affected binaries and libraries, system versions, relevant memory or process information, and available forensic images or snapshots.

Keep original artifacts protected and analyze copies when possible. Record the source, hostname or asset identifier, collection method, collector, date and time with time zone, storage location, and any transfer or access. Hash collected files or images where appropriate, preserve chain-of-custody records, and document any action that may have altered the original system. NIST’s forensic guidance discusses collecting and analyzing data from files, operating systems, network traffic, and applications while preserving evidence integrity. NIST SP 800-86, Guide to Integrating Forensic Techniques into Incident Response

Record vulnerability exploitation indicators separately from confirmed findings. For each indicator, note the source, first and last observed times, affected assets, confidence level, and any associated activity. Preserve relevant EHR audit logs securely, limit access to personnel who need them, and avoid placing unnecessary patient information in support tickets or external reports. When evidence must be shared, use an approved secure channel and coordinate with the customer.

Which temporary mitigations can reduce risk before a patch is available?

Choose compensating security controls based on how the vulnerability is reached and what the exploit can do. Possible short-term measures include restricting access to the affected endpoint, allowing only approved source systems, disabling a nonessential vulnerable feature, adding a carefully tested firewall or web-application rule, tightening privileged access, and monitoring for indicators associated with the suspected exploit.

If credentials, tokens, or sessions may have been exposed, coordinate a targeted revocation or rotation and review privileged accounts for unauthorized changes. Increase monitoring of affected services and adjacent systems, preserve the added telemetry, and ensure backups are isolated or otherwise protected from the suspected attacker. Avoid changes that erase useful evidence or interrupt clinical workflows without customer coordination.

Document each mitigation, the risk it is meant to reduce, affected configurations, remaining exposure, operational impact, and rollback conditions. Tell customers whether a workaround is temporary and what limitations it has. A compensating control can reduce risk, but it does not establish that the underlying vulnerability is fixed; keep mitigation in place until remediation is deployed and verified.

How should vendors track remediation and verify fixes?

Maintain a remediation record that links the incident, affected components and versions, customer environments, owner, severity rationale, mitigation status, patch status, and target dates. Track separate work for identifying exposure, containing active exploitation, correcting the code or configuration, releasing updates, and confirming customer deployment. Update status when evidence changes, and communicate delays or new risks to affected customers.

Before release, reproduce the issue in a controlled environment and test that the fix blocks the vulnerable behavior without breaking essential EHR functions or integrations. Include security regression tests, tests for affected versions and configurations, and relevant dependency checks. NIST’s software-verification guidance describes techniques such as threat modeling, automated testing, static analysis, and fuzzing. NIST IR 8397, Guidelines on Minimum Standards for Developer Verification of Software

Deploy in a staged, documented manner where feasible. Verify the installed version and configuration—not just the availability of a patch—and use appropriate testing or scanning to confirm that the vulnerable condition is no longer present. Monitor for renewed exploitation indicators and unexpected clinical-system effects. Keep rollback or recovery steps available, and require customer confirmation when the vendor cannot independently verify installation in a customer-controlled environment.

What information should a vulnerability report include?

Provide a clear report for customers, investigators, or a coordinated disclosure partner. Include:

• A concise title and description of the vulnerability, including affected product components, versions, configurations, and deployment conditions.
• The observed or suspected exploitation status, supporting indicators, investigation timeline, and what remains unknown.
• The potential security and operational impact, including any known effect on ePHI, EHR integrity, or clinical system availability.
• Available mitigations and their limitations, the fix or update when available, deployment instructions, and steps to verify remediation.
• A vendor contact for security updates, customer support, and coordinated disclosure; include a CVE identifier if one has been assigned.

Be precise about whether exploitation is confirmed, suspected, or not observed; do not present an absence of evidence as proof that no compromise occurred. Share only the patient information necessary for authorized investigation, using an approved secure channel. CISA’s vulnerability reporting form likewise asks for the affected product and versions, a vulnerability description, confirmation details, and security impact. CISA vulnerability reporting guidance

In short, an effective zero-day exploit response combines rapid assessment, targeted containment, careful forensic artifact preservation, temporary risk reduction, verified remediation, and clear communication—all while coordinating with dialysis providers to protect care continuity.

FAQs

What should a dialysis EHR vendor do first after detecting a suspected zero-day exploit?

Activate the incident response process, assign an incident lead, preserve relevant logs and system state, and assess which products, versions, and customer environments may be affected. Coordinate promptly with affected providers, especially where the vendor is a business associate and the BAA sets incident-reporting requirements. Treat exploitation as suspected until evidence supports a more definite conclusion.

How can affected systems be isolated without interrupting dialysis care?

Coordinate with the provider’s clinical and IT leaders, then isolate the smallest practical set of affected systems or network paths. Before disabling EHR functions, confirm whether they support active care workflows and agree on a safe alternative or downtime process. Communicate what remains available and how staff should document and reconcile work performed during an outage.

What evidence should be preserved during incident response?

Preserve relevant EHR audit logs, authentication and application records, network and cloud telemetry, endpoint alerts, configurations, affected software versions, and available system snapshots or forensic images. Record collection times with time zones, sources, handlers, storage, hashes where appropriate, and transfers. Protect evidence from alteration and avoid including unnecessary patient information in reports or tickets.

How should vendors verify that a patch or mitigation resolved the vulnerability?

Test the fix in a controlled environment, including security regression and clinical-workflow checks. After deployment, verify the actual installed version and configuration and use appropriate testing or scanning to confirm the vulnerable condition is no longer present. Monitor for renewed exploitation indicators and confirm customer environments are remediated when the vendor cannot verify them directly.